Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 88.50
Bid: 86.00
Ask: 91.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.814%)
Open: 88.50
High: 88.50
Low: 88.50
Prev. Close: 88.50
CRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value December 2012

8 Jan 2013 07:50

CRYSTAL AMBER FUND LIMITED - Net Asset Value December 2012

CRYSTAL AMBER FUND LIMITED - Net Asset Value December 2012

PR Newswire

London, January 8

8 January 2013 CRYSTAL AMBER FUND LIMITED ("Crystal Amber Fund" or the "Fund") Monthly Net Asset Value

Crystal Amber Fund announces that its unaudited net asset value ("NAV") pershare on 31 December 2012 was 120.08p (30 November 2012: 117.18p per share).

The proportion of the Fund's NAV at 31 December 2012 represented by the tenlargest holdings, other investments and cash (including accruals), was asfollows:Top ten holdings Pence per share Percentage of investee equity held TT Electronics plc 14.4 3.8% Sutton Harbour Holdings plc 12.8 27.0% Norcros plc 10.3 8.2% Devro plc 9.7 1.1% API Group plc 9.2 8.8% Northgate plc 7.7 1.1% Tribal Group plc 7.1 4.4% Smiths News plc 6.8 1.4% Renishaw plc 4.4 0.2% 4imprint Group plc 4.3 2.8% Total of ten largest holdings 86.7 Other investments 12.0 Cash and accruals 21.4 Total NAV 120.1

Investment adviser's quarterly commentary on the portfolio

Over the quarter to 31 December 2012, NAV grew by 12.3%. For the year to 31December 2012, NAV growth was 35.3%.

Key positive contributors to the NAV performance have been N Brown, SuttonHarbour, Northgate, API Group and May Gurney. Smaller negative impacts havecome from Devro and TT Electronics.

TT Electronics' share price was flat over the quarter. The Fund's holding in TThas been reduced during the period to rebalance the portfolio, and in light ofweaker trading in the automotive industry. The Fund has remained activelyengaged with the company, its largest shareholders and other stakeholders.

Sutton Harbour's share price rose by 31.8% over the quarter. This positiveshare price performance was despite a more conservative valuation of theproperty portfolio. The announcement of Sutton Harbour's indicative master-planfor development of the 113-acre former airport site has highlighted the longterm value of its assets. The completion of lease agreements for the Millbaysite has allowed Sutton Harbour to start the development of its new King PointMarina which, in due course, will add scale to its operations. Over the period,the Fund has progressed its proposals to deliver shareholder value.

Devro's share price was down 6.2% over the quarter. Following a site visit andadditional market research, we engaged in open and constructive dialogue withthe company's board. We advised management to demonstrate more clarity inmaking the investment case for Devro and have suggested additional disclosureson the opportunities for improved profitability through capital investment.Believing that the outlook for the business is favourable, our aim is to helpDevro to maximise its potential and to set appropriately stretching goals forits management. We look forward to a continuation of this engagement process.

API's share price rose by 22.1% over the quarter. Following previous boardannouncements, API initiated its sale process at the end of September byinviting tenders. In the announcement of its interim results, API confirmedthat it is in discussions with a number of interested parties. Trading resultshighlight the on-going recovery in profitability driven by normalised inputcosts and self-help measures. Following multiple site visits and researchmeetings, and despite a share price gain of 100% over 2012, we believe that APIremains undervalued.

During the quarter, Northgate's share price appreciated by 26.1%. We havepreviously highlighted the scope to achieve benefits in reducing the company'scost of capital in the current low interest rate environment. Following thecompany's interim results in December, we are pleased to note that such anapproach is gaining increasing credence with the analyst community and has leadto a share price re-rating. In December, the Fund top-sliced its holding.

During the quarter, the Fund disclosed a small position in Thorntons, theconfectioner, worth approximately £0.9m.

N Brown's share price rose by 34.6% over the quarter. The arrival of AndrewHigginson as non-executive chairman has been well received. The Fund was thefirst institutional investor to meet him in his new capacity. It was a positivemeeting and we were pleased with the new chairman's initial thoughts on thecompany. A positive trading update in October triggered a reappraisal of NBrown's prospects, which reflect the fact that it is now generating over halfof its sales online, and its favourable prospects in the US. However in ourview, pressure on disposable income of its core customers could remain aheadwind on sales performance in the medium term. Following the share pricestrength, the Fund has significantly reduced its holding in the company as theshare price achieved the Fund's price objective.

Further comments on the main investments in the portfolio can be found in theFund's 2012 Annual Report (available at www.crystalamber.com).

Share buy-back

During December, the Fund purchased 1,000,000 of its own shares at an averageprice of 104.04p per share, which are held as treasury shares. The buy-back hashad the effect of significantly reducing the share price discount to the Fund'snet asset value.

Cash resources

Following strong share price performances in a number of our holdings, the Fundbanked some profits within the portfolio. Over the quarter, cash and accrualsincreased from 9.2p per share to 21.4p per share. These cash balances willenable the Fund to take advantage of fresh investment opportunities which havebeen identified.

For further enquiries please contact:

Crystal Amber Fund LimitedWilliam Collins (Chairman)Tel: 01481 716 000Merchant Securities Limited - Nominated AdviserDavid Worlidge/Simon ClementsTel: 020 7628 2200Numis Securities Limited - BrokerNathan Brown/Hugh JonathanTel: 020 7260 1426

Crystal Amber Advisers (UK) LLP - Investment AdviserRichard BernsteinTel: 020 7478 9080

Date   Source Headline
21st Jun 20245:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jun 202410:07 amRNSMonthly Net Asset Value
18th Jun 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 20244:49 pmRNSTransaction in Own Shares and Total Voting Rights
6th Jun 20245:15 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jun 20245:43 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNSMorphic Medical – FDA approval of study amendments
3rd Jun 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20245:39 pmRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
23rd May 20241:21 pmRNSMonthly Net Asset Value
23rd May 20247:00 amRNSExtension to Share Buyback Programme
22nd May 20247:00 amRNSTransaction in Own Shares
17th May 20245:49 pmRNSTransaction in Own Shares
3rd May 20246:22 pmRNSHolding(s) in Company
2nd May 202412:37 pmRNSHolding(s) in Company
1st May 20245:22 pmRNSTransaction in Own Shares
30th Apr 20245:37 pmRNSTotal Voting Rights
29th Apr 20243:26 pmRNSHolding(s) in Company
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20247:00 amRNSHolding(s) in Company
24th Apr 20244:00 pmRNSMonthly Net Asset Value
24th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20246:22 pmRNSTransaction in Own Shares
10th Apr 20249:34 amRNSTransaction in Own Shares
3rd Apr 20244:44 pmRNSMonthly Net Asset Value
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:30 pmRNSExtension to Share Buyback Programme
28th Mar 20246:01 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20246:27 pmRNSTransaction in Own Shares
22nd Mar 20245:09 pmRNSTransaction in Own Shares
18th Mar 20245:29 pmRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20245:30 pmRNSTransaction in Own Shares
11th Mar 20244:59 pmRNSTransaction in Own Shares
7th Mar 20245:38 pmRNSTransaction in Own Shares
29th Feb 20245:30 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSNotice of Interim Results and Portfolio Update
27th Feb 20247:00 amRNSDirector/PDMR Dealing
26th Feb 20244:45 pmRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20246:02 pmRNSTransaction in Own Shares
22nd Feb 20249:28 amRNSMonthly Net Asset Value
22nd Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20245:20 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.